Can Intermittent Fasting Improve Liver Health?
A recent analysis highlights the potential metabolic benefits of specific dietary patterns in managing metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that affects nearly one-third of the global population. Formerly referred to as non-alcoholic fatty liver disease (NAFLD), MASLD is marked by excessive fat accumulation in the liver and is closely linked to obesity and type 2 diabetes. If left unchecked, it can progress to more severe complications such as inflammation, fibrosis, and even liver cancer.
The study examines three dietary approaches—Mediterranean, intermittent fasting, and DASH (Dietary Approaches to Stop Hypertension)—for their roles in addressing MASLD. Researchers explored how these diets might influence metabolic health markers associated with the condition. The findings suggest that each approach offers unique advantages for improving liver health and mitigating risk factors tied to MASLD progression. Further investigation into these dietary strategies could provide valuable insights for managing this widespread yet often silent disease.
Excerpted from Gene Online
